Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Non Operating Income (2016 - 2025)

Editas Medicine (EDIT) has disclosed Non Operating Income for 11 consecutive years, with -$68000.0 as the latest value for Q3 2025.

  • Quarterly Non Operating Income fell 1260.0% to -$68000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$6.5 million through Sep 2025, up 20.74% year-over-year, with the annual reading at -$3000.0 for FY2024, 99.81% up from the prior year.
  • Non Operating Income for Q3 2025 was -$68000.0 at Editas Medicine, up from -$1.7 million in the prior quarter.
  • The five-year high for Non Operating Income was $5.1 million in Q3 2023, with the low at -$12.5 million in Q4 2023.
  • Average Non Operating Income over 5 years is -$219105.3, with a median of $6000.0 recorded in 2024.
  • The sharpest move saw Non Operating Income soared 23600.0% in 2022, then tumbled 7183.33% in 2025.
  • Over 5 years, Non Operating Income stood at $606000.0 in 2021, then plummeted by 563.7% to -$2.8 million in 2022, then crashed by 344.06% to -$12.5 million in 2023, then skyrocketed by 65.54% to -$4.3 million in 2024, then skyrocketed by 98.42% to -$68000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$68000.0, -$1.7 million, and -$425000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.